Navigation Links Highlights the Most Important Research Expected in 2013

NORWALK, Conn., Feb. 26, 2013 /PRNewswire/ -- UBM Medica US announces spoke with leaders of seven obstetric and gynecologic societies about the most eagerly anticipated research and developments on the horizon in 2013. Developments cited include the results of the ELITE trial, which examines the effect of hormone therapy on heart health and brain function; the FDA's decision on two non-hormonal therapies for hot flashes; and evidence-based guidelines for the care of women with pregnancy complicated by hypertension and preeclampsia.

Additionally, James T. Breeden , MD, the president of the American Congress of Obstetrics and Gynecology (ACOG), America's largest ob/gyn society, reasserted the organization's commitment to family planning services in 2013.

Experts also commented on the most important developments of 2012, which included American Society for Reproductive Medicine's (ASRM) removal of the 'experimental' label from the procedure of oocyte cryopreservation, and discoveries into the complex genetic processes involved in ovarian cancer.

Surveyed societies include the American Congress of Obstetrics and Gynecology (ACOG), American Society for Reproductive Medicine (ASRM), Society for Maternal and Fetal Medicine (SMFM), North American Menopause Society (NAMS), Society of Gynecologic Oncology (SGO), American Urogynecologic Society (AUS), and the Royal College of Obstetricians and Gynaecologists (RCOG).

About UBM Medica US
Addressing today' s healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include,,,,,, and UBM Medica US is part of UBM Connect – which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit

Media contact:
Jason J. Golden
Content Marketing Manager

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Power Wheelchairs Supplier Highlights Upcoming Changes to Medicare Competitive Bidding Program
2. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
3. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
4. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
5. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
6. CTIA-The Wireless Association Highlights Connected Health Benefits and Potential
7. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
8. Philips Highlights Future Innovations at RSNA 2012 Transformation Lab
9. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
10. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
11. Zacks Sell List Highlights: J.C. Penney, Spirit AeroSystems Holdings, The New York Times and Jazz Pharmaceuticals
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just ... is offering customers 10% off of their purchase of lice treatment product. In addition, ... price. According to a company spokesperson. “Finding lice is a sure way to ruin ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced today that ... (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics SL ERP ... partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ongoing commitment ...
(Date:11/27/2015)... Chicago, IL (PRWEB) , ... November 27, 2015 ... ... some of the largest, most successful and prominent nonprofit healthcare organizations in the ... and governance involvement with various organizations, and helped advance the healthcare industry as ...
(Date:11/26/2015)... NV (PRWEB) , ... November 26, 2015 , ... Inevitably ... strategy. Many customers choose to buy during the Black Friday and Cyber Monday ... Shoppers don’t need to search the Internet high and low to find the best ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
Breaking Medicine News(10 mins):